Comparative outcomes of predominant facility-level use of ferumoxytol versus other intravenous iron formulations in incident hemodialysis patients

BACKGROUND: Ferumoxytol was first approved for clinical use in 2009 solely based on data from trial comparisons with oral iron on biochemical anemia efficacy end points. To compare the rates of important patient outcomes (infection, cardiovascular events and death) between facilities predominantly u...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Nephrol Dial Transplant
Prif Awduron: Airy, Medha, Mandayam, Sreedhar, Mitani, Aya A., Chang, Tara I., Ding, Victoria Y., Brookhart, M. Alan, Goldstein, Benjamin A., Winkelmayer, Wolfgang C.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Oxford University Press 2015
Pynciau:
Clinical Science
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4829057/
https://ncbi.nlm.nih.gov/pubmed/26311216
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndt/gfv305
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg